TruthArchive.ai - Related Video Feed

CMS is currently offering a 20% bonus payout to hospitals that choose to use Remdesivir for Medicare aged patients. This drug is supposedly approved by the FDA and recommended by the NIH for COVID-19 treatment. However, it is known to cause kidney, heart, and liver failure. Hospitals are also being incentivized to PCR test every patient, regardless of the reason for their visit, in order to increase their numbers. The federal government pays a monthly bribe based on the percentage of PCR tests conducted. Hospitals receive a 20% bonus for every positive COVID-19 diagnosis, as well as for using Remdesivir and ventilating patients. Additionally, they receive further incentives for every COVID-19 death, amounting to $9,000 per case per month. The reasons behind these incentives remain unclear.

Transparency and outcome-based funding are key solutions. CMS data showed a 90% ventilator mortality rate in Texas, worse than Russian roulette. Hospitals are allegedly incentivized to use specific protocols. Hospitals get paid more for testing, COVID admission, remdesivir, ventilation, and death. This allegedly incentivizes patient murder over treatment. The public should decide if they want to incentivize good hospital outcomes or the alleged murder of loved ones.

Hospitals are receiving financial incentives for COVID-related cases, leading to concerns about patient care and transparency. The CARES Act offers bonus payments for COVID diagnoses, while the Center for Medicare and Medicaid Services is waiving patient rights. Hospitals receive payments for offering free COVID tests, diagnosing COVID, admitting COVID patients, administering Remdesivir, using mechanical ventilators, and even listing COVID on death certificates. There are also bonus payments to coroners. This combination of incentives has raised concerns about hospitals prioritizing financial gain over patient well-being. The estimated payment per patient is around $100,000. The situation is alarming, and urgent action is needed to address these issues.

The CDC and NVSS changed death certificate reporting in violation of federal law. Two days later, the HHS increased reimbursement for hospitals and doctors who listed everything as COVID, making it the most lucrative diagnosis. There are reports of patients being starved and denied water, possibly to increase the use of Remdesivir. The range of fraudulent death certificates is estimated to be between 88.6% and 94.0%. Reimbursement for a diabetic patient labeled as COVID is 3 to 6 times higher. Hospitals had to go along with this to stay in business. Doctors who spoke up were threatened with license revocation and faced censorship. This is seen as collusion and murder for profit.

The speaker claims that unvaccinated individuals entering hospitals were deliberately killed. According to the speaker, every unvaccinated person they interviewed who went to the hospital reported not receiving the same treatments as vaccinated patients. Instead, they were allegedly given remdesivir, ventilation, and fentanyl, leading to their deaths. Another speaker adds that hospitals had financial incentives to produce COVID-related deaths, allegedly receiving up to $500,000 per death in California. The first speaker agrees, stating that hospital coders and whistleblowers revealed that patients were repeatedly tested for COVID until a positive result was obtained, triggering payments. They claim hospitals received additional payments for each drug and piece of equipment used, totaling over $500,000 per person. One person allegedly said their daughter was worth more dead than alive.

When someone dies with COVID-19, it's counted as a COVID-19 death, not just an infection. Doctors are being paid more for listing patients as COVID-19 cases, with $13,000 for a COVID-19 admission and $39,000 if the patient goes on a ventilator. Some believe this treatment approach is wrong and could harm many people.

Unvaccinated patients entering the hospital reported being treated differently based on their vaccination status. Those who had not received the COVID-19 shot were quickly given treatments like remdesivir and placed on ventilators, leading to a high mortality rate. There are claims that hospitals had financial incentives to classify deaths as COVID-related, with some receiving substantial payments for each case. Whistleblowers from within the healthcare system indicated that staff were pressured to ensure positive COVID tests to secure funding. The financial motives behind these practices raised serious ethical concerns, with one individual stating that their loved one was valued more dead than alive due to these incentives.

Many nurses witnessed patients dying not from COVID, but from medical mismanagement like using remdesivir and ventilators. One nurse highlighted the lack of feeding tubes for ventilator patients. Placing patients on ventilators without feeding tubes led to starvation and death. The focus on ventilators instead of proper care caused harm, with many patients not surviving the treatment. Early intubation was pushed to contain the virus, resulting in high mortality rates for ventilated patients. The situation in hospitals was distressing and poorly managed.

Actions were taken to promote the vaccine by inflating COVID numbers through protocols in 2020. Hospitals were incentivized to label patients as COVID, put them on ventilators, administer Remdesivir, and profit from deaths. The goal was to instill fear and push vaccinations. Hospital administrators, driven by financial incentives, unknowingly contributed to unnecessary deaths. This greed-driven system continues to harm people.

Patients are dying not from COVID, but from treatments like remdesivir causing organ failure. One person's mother died after being given remdesivir against their wishes, leading to organ shutdown. There was a financial incentive for hospitals to admit patients and put them on ventilators, resulting in unnecessary treatments and deaths.

The stimulus bill intended to help hospitals overrun with COVID patients created an incentive to record something as COVID. Hospitals are in a bind because if a hospital is half full, it's hard to make ends meet. Checking a box can yield $8,000, and putting a patient on a ventilator for five minutes can bring $39,000. The alternative could be firing doctors. This situation presents a tough moral quandary.

Noninvasive ventilation like CPAP or BiPAP is not being used in some New York City hospitals due to COVID. Patients are quickly put on ventilators, neglecting other treatments. Nurses report patients being left to die without proper care or family support. Ventilators cause lung trauma, with high pressure and sedation protocols. Traditional treatments like hydroxychloroquine, zinc, and vitamins are not being used, despite patient consent being obtained without full understanding.

Our initial response to COVID incentivized hospitals to prioritize profit over patient care, leading to questionable treatment decisions. Medical boards, influenced by financial gain, hindered effective protocols like those of Doctor Bartlett. This highlights the need to hold medical boards accountable for prioritizing money over patient well-being.

Speaker 0: There were four drugs that were being tested for Ebola. Remdesivir killed more people than placebo, and the data safety monitoring board had actually stopped the study where literally fifty three percent of Speaker 1: the patients died in the failed Ebola trial and was repurposed. It was a failed Ebola drug because it caused more harm than good in Ebola trials. It was still unpatent. It was Tony Fauci's drug of choice. The majority of hospital deaths were actually caused by Anthony Fauci because his NIH put out protocols that if the hospital systems adhered to, they got bonuses, big bonuses, lots of money, $3,000 per for putting an IV in of remdesivir. Boom. $3,000. But guess what? On top of the entire hospital stay, a 20% bonus, that could be hundreds of thousands of dollars. Speaker 0: The data was so overwhelming that remdesivir killed patients more so than placebo. The drug had to be stopped, and this was published in the New England Journal in the 2019. Speaker 2: What happened during COVID could not have happened without propaganda and censorship. And how do we overcome that propaganda and censorship? It's primarily through people not being willing to shut up.

Hospitals are receiving bonus payments for COVID cases, leading to high mortality rates and lack of transparency for families. The CARES Act incentivizes hospitals with payments for COVID tests, diagnoses, admissions, remdesivir use, ventilator use, and even COVID-related deaths on death certificates. This system is seen as the Biden administration paying hospitals to harm patients, with estimated payments of $100,000 per patient. The situation is dire and needs to be addressed urgently.

We ended our previous episode with our COVID pyramid, build layer upon layer of lies, deceit, fraud, scandals. Now, by now you’re wondering how so many hospitals, doctors, and health care workers went along with all of the above. We have reached the capstone of our nauseating COVID pyramid. Pyramid. We shall name the capstone M and M, money and murder in hospitals. Shocking as it may sound, we’ve seen it before. Remember the unjust administering the killer drug midazolam in The UK as shown in part 19? Well, The US and many other countries had their own version called remdesivir. Here’s what happened. Hospitals were given incentives, as in money, for each and every COVID casualty. According to whistleblowers, investigative journalists, lawyers, and specialists, Hospitals in The US have been receiving $13,000 for every admitted COVID patient. There have been financial extras for every COVID test, for every positive outcome. If patients were treated with the only prescribed drug, remdesivir, the hospital received yet another bonus: 20% of the entire hospital bill of the patient. Then for every patient put on a ventilator, the hospital received $39,000. And if that patient officially died of COVID nineteen, they got yet another $13,000. That’s a lot of money. According to attorney Thomas Renz and CMS whistleblowers, the hospitals receive approximately $100,000 per COVID casualty if the above protocol was followed. Now the thing is, the American hospitals received this money in advance based on the COVID predictions, based on the flawed models of people like Brooks. If the hospitals didn’t actually meet those models, they had to pay that money back at a later stage. And we’re talking millions of dollars here. So what happened? Everybody who was admitted to a hospital, for instance because of a car accident or because of cancer or diabetes or kidney failure, everybody got a PCR test to start with. Due to the ridiculous amount of cycles, there was an abundance of false positives. False positives equals positives equals COVID patients equals money. Hence, the sunrise in COVID patients. Then remdesivir left its detrimental mark just like midazolam had done in The UK. You see, remdesivir is not a new drug. It was used in 2018 during the West African Ebola outbreak. It was known to have severe adverse effects such as kidney damage, liver damage, and even death. Yet in 2020, Anthony Fauci directed that remdesivir was to be the drug hospitals used to treat COVID nineteen, hence the incentives. So what happened next? Those poor patients only got worse, after which they were put on a ventilator. After all, that was yet another bonus of many thousands of dollars pouring straight into the pockets of the hospitals. Now the problem with ventilators is that the patient is put into an induced coma. His or her breathing is taken over by a machine that puts extra pressure on the lungs called barrow pressure. In the case of damaged lungs due to for instance pneumonia, those lungs will only get worse. The chances of that patient recovering, of being able to be taken off the ventilator and to start breathing by himself are very, very small. Combined with organ failure as a result of remdesivir, the chances of that patient ever leaving the hospital alive are next to nothing.

There is a high demand for ventilators due to COVID-19. Non-COVID patients typically need them for 3 to 4 days, while COVID patients require them for 11 to 21 days. Businesses want to make money and open their factories, so they need the necessary supplies. Ordering only 400 ventilators when 30,000 are needed means choosing which 26,000 people will die. The speaker emphasizes the importance of understanding the demand for ventilators and supporting businesses to help them meet the demand.

America is counting all deaths with COVID-19 as COVID-19 deaths, not just those caused by the virus. Doctors claim they are incentivized to label patients as COVID-19 cases for financial gain, with $13,000 paid by Medicare for each COVID-19 hospital admission and $39,000 if the patient goes on a ventilator. This has led to concerns about misdiagnosis and inappropriate treatment.

CMS is currently offering a 20% bonus payout to hospitals that choose to use remdesivir for all Medicare aged patients. This drug is supposedly approved by the FDA and recommended by the NIH for COVID-19 treatment. However, it is known to cause kidney, heart, and liver failure. Hospitals are also being incentivized to PCR test every patient, regardless of the reason for their visit, and are paid a bribe for the percentages of positive COVID-19 diagnoses. Additionally, hospitals receive a 20% bonus for using remdesivir, ventilating patients, and for every COVID-19 death, earning up to $9,000 per case per month. The reasons behind these incentives remain unclear.

Many nurses witnessed patients dying not from COVID, but from medical mismanagement like using remdesivir and ventilators. One nurse highlighted the lack of feeding tubes alongside ventilators, emphasizing the importance of proper care. Patients were intubated early, leading to high mortality rates. The medical system's focus on COVID treatments caused harm, with nurses bearing the brunt of patient care.

A nurse and a doctor discuss the use of ventilators in hospitals during the pandemic. The nurse reveals that some floors were carrying out actions that other floors refused to do, essentially causing harm to patients. The doctor mentions that ventilators were used to protect healthcare workers, even though they had a high fatality rate for patients. The lack of transparency with patients and families is highlighted, as well as the reluctance to explore alternative treatments like Ivermectin or hydroxychloroquine. The speaker also mentions the incentivization of using certain drugs and protocols that led to unnecessary deaths.

In this video, the speakers discuss the use of ventilators in treating COVID-19 patients. They mention that a high percentage of people put on ventilators have died. The first speaker shares that doctors in Wuhan admitted to making a mistake by putting too many people on ventilators for an extended period, which actually damages the lungs. The second speaker questions the demand for ventilators and suggests that non-COVID patients typically use them for 3 to 4 days, while COVID patients are kept on them longer to get them back to work. They emphasize the need for more ventilators and criticize the allocation of limited supplies. The video ends with a statement about the desire for businesses to make money.

The speaker discusses the use of ventilators in treating COVID-19 patients. They mention that the concept of using ventilators came from China as a way to protect healthcare workers. However, they point out that many patients put on ventilators in New York City were dying, with a 90% fatality rate in some Texas hospitals. The speaker questions why alternative treatments like ivermectin or hydroxychloroquine were not considered when the chances of survival were so low. They also mention the incentivization of using certain drugs and protocols that may have contributed to unnecessary deaths.

Patients were desperate for ivermectin as their loved ones died, but the focus shifted to remdesivir, a previously failed Ebola drug. By November 2020, the World Health Organization advised against its use, citing ineffectiveness and potential kidney and liver damage. The European Society of Critical Care supported this stance. Despite the warnings, the U.S. Health and Human Services incentivized hospitals with a 20% bonus for administering remdesivir, leading to widespread use. It failed to reduce mortality and caused serious injuries, with some patients dying as a result. In May 2022, the WHO reaffirmed its initial decision, stating that remdesivir should never have been used.

According to the speaker, hospital protocols differed for vaccinated and unvaccinated COVID-19 patients, with more aggressive protocols used on the unvaccinated. The unvaccinated patients interviewed were often given remdesivir, a repurposed drug from a failed Ebola trial where about half the patients died. The speaker claims the efficacy data for remdesivir was "sketchy at best," but hospitals received large reimbursements for its use. The speaker alleges that patients would then be put on oxygen, then mechanical ventilation, then ICU, and finally, if they resisted, a cocktail of sedatives and sometimes four-point restraints to prevent them from leaving. The speaker states that "a lot of the patients died." The speaker claims that at each step, the hospital received more reimbursement, and there was "lockstep adherence" to the protocol.